Hepatic Expression of Apolipoprotein E Inhibits Progression of Atherosclerosis without Reducing Cholesterol Levels in LDL Receptor-Deficient Mice
Open Access
- 29 February 2000
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 1 (2) , 189-194
- https://doi.org/10.1006/mthe.2000.0028
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Macrophages, lipoprotein metabolism, and atherosclerosisCurrent Opinion in Lipidology, 1999
- Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophagesProceedings of the National Academy of Sciences, 1997
- Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.Journal of Clinical Investigation, 1995
- Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation.Journal of Clinical Investigation, 1995
- Prevention of Atherosclerosis in Apolipoprotein E-Deficient Mice by Bone Marrow TransplantationScience, 1995
- Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption.Journal of Clinical Investigation, 1994
- ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein EScience, 1992
- Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cellsPublished by Elsevier ,1992
- Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell BiologyScience, 1988